Bullbobagginz Posted - 1 hour ago

$AKBA What has changed since approval?

Bullbobagginz Posted - 1 hour ago

$AKBA What has changed since 5 days ago?

jballer96 Posted - 2 hours ago

$AKBA Does potential not count in this market? What’s the point of forecasts if it’s all about now?! How can we be this low after approval and enough cash on hand for the next 2 years? The market is starting to frustrate me. I see other stocks moving on no news/fundamentals while we decline. This stock decline on good news, bad news, no news….it’s odd at this point. Still

Hogtrader1 Posted - 3 hours ago

$AKBA I actually had a break even out at approval and didn’t take it. Man I won’t do that again with Butler in charge. Just unbelievable watching this trainwreck with no leadership and horrible investor relations.

Investman13 Posted - 4 hours ago

$AKBA

Investman13 Posted - 4 hours ago

$AKBA

Investman13 Posted - 4 hours ago

$AKBA are these Tax sales? Hadas and Dahan

jd_76 Posted - 5 hours ago

$AKBA GME and AMC at it again can’t we get they kind grass roots love here

BooksandTennis Posted - 5 hours ago

$AKBA actually, I thought we would end below last week's close... Nice to see $1.29... good rational strength...

PlsStonks Posted - 5 hours ago

$AKBA nice Green Day, let’s hope the trend continues and we break that 1.30 wall tomorrow

mAGABOON Posted - 6 hours ago

$AKBA

Lorenzo89 Posted - 6 hours ago

$AKBA can we get some of that AMC over here !!?

georgeyann Posted - 6 hours ago

$AKBA to the moon

fresh10 Posted - 8 hours ago

$AKBA when does the new drug hit market??

Debhin Posted - 8 hours ago

$AKBA Who took the 4 cent loss AH? Fess up.

buythehornz127 Posted - 8 hours ago

$AKBA AKBA CATALYSTS & EVENTS JUNE 2024 - (1)Akebia will submit TDAPA reimbursement application to Centers for Medicare Services (CMS); (2)Akebia will set wholesale acquisition cost pricing; (3)Medice plans to launch Vadadustat dialysis dependent indication in Germany and Austria; (4)Akebia’s stockholder meeting - election of directors, amendment of stock incentive plan (9,800,000), compensation for executives, Ernst & Young ratification; (5)Nicole Hadas, Chief Legal Officer/Senior VP/Corporate Secretary and Michael Dahan, Chief Operating Officer/Senior VP departure dates June 14/28, 2024; (6)Big Pharma buyout? (7)Inducement grants. 😎 JUNE IS JUMPING! @PappyVan

demetrin Posted - 8 hours ago

$AKBA

PappyVan Posted - 8 hours ago

$AKBA Strong close! 💚🍀

Investman13 Posted - 8 hours ago

$AKBA Lambo

Squeezepepper Posted - 8 hours ago

$AKBA Nice close. Unequivocally

Maiquyen003 Posted - 8 hours ago

$ALT $akba $vnda shorted gme at $37 covered at $30. Now, back to my 3 babies.

blackbeef Posted - 8 hours ago

$AKBA garbage

buythehornz127 Posted - 10 hours ago

$AKBA AS FOR ME, I LIKE THE STOCK - (1)Vadadustat DD approved in 37 countries. Poised to disrupt multi billion dollar 💵 ESA market. “$2B market potential.” Akebia’s Exhibit 99.1. Butler “$1B plus market opportunity.”(2)Vadadustat NDD worldwide. Engage w/ FDA concerning positive risk benefit patient population subset. Doubles economics. $2B plus? (3)AKB 9090 ARDS. $27B~ worldwide market 2030. Unmet medical need. FDA fast track designation? (4)Auryxia USA $175~ 2024. Slope not cliff drop off after patent expiry? (5)Auryxia Europe? (6)Vadadustat Covid-19/ARDS phase 3 clinical trial? (7)AKB 9090 Acute Kidney Injury? (8)AKB 10108 Retinopathy of Prematurity? (9)AKB 10108 Broncho Pulmonary Dysplasia? (10)Praliciguat global phase two? (11)Cash for operations for more than two years; (12)Financial discipline. Principal payments and debt maturity deferred until after TDAPA; (13)Nobel award prize in science and medicine. Good luck 🍀 to us.

KarlDieGlatze Posted - 11 hours ago

$AKBA Deepa Sarvaiya wrote about revenues NOT RAMPING for "years" on Seeking Alpha with a sanguine, or blood thirsty bad review of AKBA's prospects suggesting avoidance after last week's earnings. Who is this woman?

Too_Soon Posted - 11 hours ago

$AKBA

Legacy24 Posted - 11 hours ago

$AKBA this bear/bull meter is pointless lol. May/June will be a good month!!!

simplehumble Posted - 12 hours ago

$ESPR - I see huge loading going on at the cheap price. Loaded another 7K at 2.17. Just following the manipulator/crooks (i.e smart money). Chart says 3:30$+ is coming in few days. Probably in June 1st week or early. If we can break 3:30$ then path to 5$+ going to be smooth. We have tried to break 3.30$ 3 times in the recent past. For some reasons, I think we gonna break it this time. Why? 1. After this type of earning, stock cant go down. Its a temporary manipulation. 2. Lots a revenue coming down the line I subscribe to a premium tool which predicts price would be approximately to 10$ in coming weeks/months. Sold some other stocks and loaded $ESPR and $AKBA. Both of them are good candidate of buy out. Do your DD. Check twitter(Gary & Brink) for some great DD. Pumpers and bashers both are bad but pumpers do the most harm(life lesson). This is how do my DD: 1. Check the chart and follow the trends (20MA, 50 MA, MACD) 2. Check the research in twitter and Stocktwits

ROCKET123 Posted - 12 hours ago

$AKBA Where else can you find a company sitting on US and worldwide approvals with a multibillion dollar pipeline, full of cash and a SP still under $2 bucks?…not for long…hmmm💎

KarlDieGlatze Posted - 12 hours ago

$AKBA Second, I think about differentiation versus the existing HIF in the marketplace. Today, we spend a lot of time talking about their label and the risk it poses for people with a history of heart failure. 40% of that population has a history of heart failure and therefore differentiation versus the other HIF is high.

KarlDieGlatze Posted - 12 hours ago

$AKBA The second piece around value I think about is the frequency of overshoots and undershoots, how hard it is for dialysis organizations and physicians to manage hemoglobin within a relatively tight range. All that value goes into the product and the value of the price.